These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 20473206

  • 1. An integrated evidence rating to frame comparative effectiveness assessments for decision makers.
    Ollendorf DA, Pearson SD.
    Med Care; 2010 Jun; 48(6 Suppl):S145-52. PubMed ID: 20473206
    [Abstract] [Full Text] [Related]

  • 2. Maximizing the clinical utility of comparative effectiveness research.
    Umscheid CA.
    Clin Pharmacol Ther; 2010 Dec; 88(6):876-9. PubMed ID: 20962776
    [Abstract] [Full Text] [Related]

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methodological challenges of comparative effectiveness research in pain: implications for investigators, clinicians, and policy makers.
    Bellows BK, Biskupiak J.
    J Pain Palliat Care Pharmacother; 2011 Nov; 25(3):267-74. PubMed ID: 21882980
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD.
    Best Pract Res Clin Haematol; 2005 Nov; 18(3):439-48. PubMed ID: 15792918
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T, Abrams KR, Ament AJ, Evers SM, Severens JL.
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [Abstract] [Full Text] [Related]

  • 13. The role of costs in comparative effectiveness research.
    Garber AM, Sox HC.
    Health Aff (Millwood); 2010 Oct; 29(10):1805-11. PubMed ID: 20921479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical Oncology.
    J Clin Oncol; 2009 Aug 10; 27(23):3868-74. PubMed ID: 19581533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Translating comparative effectiveness into practice: the case of diabetes medications.
    Shah ND, Mullan RJ, Breslin M, Yawn BP, Ting HH, Montori VM.
    Med Care; 2010 Jun 10; 48(6 Suppl):S153-8. PubMed ID: 20473211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.